{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:27:05Z","timestamp":1792106825121,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40744-024-00699-6","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:21:11Z","timestamp":1722262871000},"page":"1255-1269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Over Activation of IL-6\/STAT3 Signaling Pathway in Juvenile Dermatomyositis"],"prefix":"10.1007","volume":"11","author":[{"given":"Qi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8097-614X","authenticated-orcid":false,"given":"Meiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"699_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41584-023-00967-9","volume":"19","author":"C Papadopoulou","year":"2023","unstructured":"Papadopoulou C, Chew C, Wilkinson MGL, McCann L, Wedderburn LR. Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. Nat Rev Rheumatol. 2023;19:343\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"699_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"N Ruperto","year":"2016","unstructured":"Ruperto N, Pistorio A, Oliveira S, et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet (London, England). 2016;387:671\u20138.","journal-title":"Lancet (London, England)"},{"key":"699_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13075-020-02160-9","volume":"22","author":"H Kim","year":"2020","unstructured":"Kim H, Gunter-Rahman F, McGrath JA, et al. Expression of interferon-regulated genes in juvenile dermatomyositis versus mendelian autoinflammatory interferonopathies. Arthritis Res Ther. 2020;22:69.","journal-title":"Arthritis Res Ther"},{"key":"699_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/art.40800","volume":"71","author":"GM Moneta","year":"2019","unstructured":"Moneta GM, Pires Marafon D, Marasco E, et al. Muscle expression of type i and type ii interferons is increased in juvenile dermatomyositis and related to clinical and histologic features. Arthritis Rheumatol (Hoboken, NJ). 2019;71:1011\u201321.","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"699_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/art.40328","volume":"70","author":"C Gitiaux","year":"2018","unstructured":"Gitiaux C, Latroche C, Weiss-Gayet M, et al. Myogenic progenitor cells exhibit type i interferon-driven proangiogenic properties and molecular signature during juvenile dermatomyositis. Arthritis Rheumatol (Hoboken, NJ). 2018;70:134\u201345.","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"699_CR6","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar4311","volume":"15","author":"K Nistala","year":"2013","unstructured":"Nistala K, Varsani H, Wittkowski H, et al. Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis. Arthritis Res Ther. 2013;15:R131.","journal-title":"Arthritis Res Ther"},{"key":"699_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/art.41078","volume":"72","author":"B Duvvuri","year":"2020","unstructured":"Duvvuri B, Pachman LM, Morgan G, et al. Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis. Arthritis Rheumatol (Hoboken, NJ). 2020;72:348\u201358.","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"699_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s42003-022-04088-z","volume":"5","author":"A Lovri\u0107","year":"2022","unstructured":"Lovri\u0107 A, Rassolie A, Alam S, et al. Single-cell sequencing deconvolutes cellular responses to exercise in human skeletal muscle. Commun Biol. 2022;5:1121.","journal-title":"Commun Biol"},{"key":"699_CR9","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al. 2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol (Hoboken, NJ). 2017;69:2271\u201382.","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"699_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","volume":"72","author":"D Lazarevic","year":"2013","unstructured":"Lazarevic D, Pistorio A, Palmisani E, et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis. 2013;72:686\u201393.","journal-title":"Ann Rheum Dis"},{"key":"699_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3171\/2008.12.JNS081284","volume":"111","author":"M Kudo","year":"2009","unstructured":"Kudo M, Jono H, Shinriki S, et al. Antitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation. Laboratory investigation. J Neurosurg. 2009;111:219\u201325.","journal-title":"J Neurosurg"},{"key":"699_CR12","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1080\/21655979.2021.1964158","volume":"12","author":"F Han","year":"2021","unstructured":"Han F, Li S, Yang Y, Bai Z. Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis. Bioengineered. 2021;12:5279\u201388.","journal-title":"Bioengineered"},{"key":"699_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12969-017-0174-0","volume":"15","author":"CH Spencer","year":"2017","unstructured":"Spencer CH, Rouster-Stevens K, Gewanter H, et al. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the childhood arthritis and rheumatology research alliance in North America. Pediatr Rheumatol Online J. 2017;15:50.","journal-title":"Pediatr Rheumatol Online J"},{"key":"699_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.635654","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Li W, Jiang W, et al. The efficacy of tocilizumab in the treatment of patients with refractory immune-mediated necrotizing myopathies: an open-label pilot study. Front Pharmacol. 2021;12: 635654.","journal-title":"Front Pharmacol"},{"key":"699_CR15","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1093\/rheumatology\/keaa906","volume":"60","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhou S, Wu C, et al. Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis. Rheumatology (Oxford). 2021;60:e227\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"699_CR16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrrheum.2014.127","volume":"10","author":"LH Calabrese","year":"2014","unstructured":"Calabrese LH, Rose-John S. Il-6 biology: implications for clinical targeting in rheumatic disease. Nat Rev Rheumatol. 2014;10:720\u20137.","journal-title":"Nat Rev Rheumatol"},{"key":"699_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/315365","volume":"2013","author":"M Hristova","year":"2013","unstructured":"Hristova M, Dourmishev L, Kamenarska Z, et al. Role of the promoter polymorphism il-6 -174g\/c in dermatomyositis and systemic lupus erythematosus. Biomed Res Int. 2013;2013: 315365.","journal-title":"Biomed Res Int"},{"key":"699_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3109\/14397595.2013.844390","volume":"24","author":"M Nara","year":"2014","unstructured":"Nara M, Komatsuda A, Omokawa A, et al. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Mod Rheumatol. 2014;24:633\u20136.","journal-title":"Mod Rheumatol"},{"key":"699_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.tem.2016.08.006","volume":"27","author":"M Pant","year":"2016","unstructured":"Pant M, Bal NC, Periasamy M. Sarcolipin: a key thermogenic and metabolic regulator in skeletal muscle. Trends Endocrinol Metab. 2016;27:881\u201392.","journal-title":"Trends Endocrinol Metab"},{"key":"699_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1096\/fba.2019-00070","volume":"2","author":"B \u00d6zt\u00fcrk Akcora","year":"2020","unstructured":"\u00d6zt\u00fcrk Akcora B, Vassilios Gabri\u00ebl A, Ortiz-Perez A, Bansal R. Pharmacological inhibition of stat3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells. FASEB Bioadv. 2020;2:77\u201389.","journal-title":"FASEB Bioadv"},{"key":"699_CR21","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/cancers11101618","volume":"11","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buse M, Busuioc C, et al. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers. 2019;11:1618.","journal-title":"Cancers"},{"key":"699_CR22","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1158\/1078-0432.CCR-15-0858","volume":"22","author":"Y Yao","year":"2016","unstructured":"Yao Y, Ye H, Qi Z, et al. B7\u2013h4(b7x)-mediated cross-talk between glioma-initiating cells and macrophages via the il6\/jak\/stat3 pathway lead to poor prognosis in glioma patients. Clin Cancer Res. 2016;22:2778\u201390.","journal-title":"Clin Cancer Res"},{"key":"699_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-1028-5-14","volume":"5","author":"A Jarnicki","year":"2010","unstructured":"Jarnicki A, Putoczki T, Ernst M. Stat3: linking inflammation to epithelial cancer\u2014more than a \u201cgut\u201d feeling? Cell Div. 2010;5:14.","journal-title":"Cell Div"},{"key":"699_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.625680","volume":"9","author":"LAM de Barcellos","year":"2021","unstructured":"de Barcellos LAM, Gon\u00e7alves WA, de Oliveira MPE, et al. Effect of physical training on exercise-induced inflammation and performance in mice. Front Cell Dev Biol. 2021;9: 625680.","journal-title":"Front Cell Dev Biol"},{"key":"699_CR25","first-page":"9148246","volume":"2022","author":"B Yang","year":"2022","unstructured":"Yang B, Yang X, Sun X, Shi J, Shen Y, Chen R. Il-6 deficiency attenuates skeletal muscle atrophy by inhibiting mitochondrial ROS production through the upregulation of pgc-1\u03b1 in septic mice. Oxid Med Cell Longev. 2022;2022:9148246.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-024-00699-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T06:07:32Z","timestamp":1727158052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-024-00699-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1007\/s40744-024-00699-6","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Qi Zheng, Zhaoling Wang, Yejun Tan, Kun Zhu, and Meiping Lu announce that there is no conflict of interests among them.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Informed consent was obtained from guardians as well as subjects aged over 8 years. The study was approved by institutional research ethics committee of Zhejiang University School of Medicine (2021-IRBAL-303).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}